Omega Therapeutics (OMGAQ) Stock Chart & Stock Price History $0.02 -0.04 (-63.00%) As of 07/18/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Omega Therapeutics Stock Price Performance The Omega Therapeutics (OMGAQ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.76%, with a year-to-date return of -97.02%. In the past month, the stock has decreased 82.24%, reflecting recent market activity. As of the latest close, Omega Therapeutics traded at $0.02 with a market cap of $1.23 million and volume of 294,621 shares. Receive OMGAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-64.37%1 Month Performance-82.24%3 Month Performance-82.24%Year-To-Date Performance-97.02%1 Year Performance-98.76% OMGAQ Stock Chart for Sunday, July, 20, 2025 OMGAQ Chart by TradingView Omega Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$0.06$0.02-63.00%$0.08$0.01294,621 shs$1.23 million07/17/2025$0.06$0.06-3.38%$0.07$0.041.07 million shs$3.32 million07/16/2025$0.06$0.06-0.32%$0.07$0.04796,398 shs$3.44 million07/15/2025$0.06$0.06-2.81%$0.08$0.06515,743 shs$3.45 million07/14/2025$0.13$0.06-48.72%$0.09$0.06654,001 shs$3.55 million07/11/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/10/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/09/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/08/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/07/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million Get the Latest News and Ratings for OMGAQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/03/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/02/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million07/01/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/30/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/27/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/26/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/25/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/24/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/23/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/20/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million06/19/2025$0.13$0.13$0.17$0.144.81 million shs$6.92 million Related Companies MetaVia Stock Chart Briacell Therap Stock Chart Leap Therapeutics Stock Chart TherapeuticsMD Stock Chart NKGen Biotech Stock Chart IM Cannabis Stock Chart iBio Stock Chart Acurx Pharmaceuticals Stock Chart Trinity Biotech Stock Chart 23andMe Stock Chart Receive OMGAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OMGAQ) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredSteve Jobs' Deathbed Secret Finally LeakedLeaked: Jobs’ Final Apple Project Exposed Bloomberg just leaked details of a secret project Steve Jobs set ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
